At 1:09 p.m. on Sunday, July 19, 2026, Elizabeth Baron was pronounced dead at NewYork-Presbyterian Allen Hospital with an IV catheter still lodged in her right hand.
She was 27. About an hour earlier, she had walked into the Bereshit Lifestyle Center on Riverdale Avenue in the Bronx for an anti-aging infusion.
The man who inserted that line, 55-year-old Luis Rojas Cabrera, gave police a confession that doubles as an indictment of the entire field. He told officers he administered an intravenous infusion of NAD⁺ into her right hand, and that she went unconscious "immediately."
Then, per the criminal complaint quoted by Gothamist, he explained who he actually was.
"I am a doctor in the Dominican Republic. I have a PA license in Puerto Rico. I am not a licensed doctor in New York. My application is pending. I only have an esthetician license."
An esthetician license. The credential to do facials was reportedly the credential behind the needle.
Shortly after Baron was pronounced dead, Cabrera reportedly told police something else, according to the complaint: "I made a very big mistake. I need to call my family because I have a feeling I will not be home for a while."
He was reportedly charged with reckless endangerment and unauthorized practice of a profession, released without bail pending autopsy, and ordered to surrender his passport (though Israeli outlet Ynet reported he pleaded not guilty to second-degree manslaughter and unauthorized practice of a profession). Prosecutors have signaled the charges could be upgraded once toxicology returns.
The temptation is to read this as a freak accident — one rogue operator, one catastrophic reaction. It was not. It was the predictable output of a system built to move faster than any agency can police it.
Start with the intervention itself, because this is where the field has to be honest. IV NAD⁺ infusion, marketed as a longevity treatment, carries essentially no clinical evidence for its anti-aging claims.
Human data on NAD⁺ biology is thin to begin with, and it clusters around oral precursors like NR and NMN, not the infused molecule. That precursor literature has its own translational failures — including a null result in the National Institute on Aging's rigorous Intervention Testing Program — which a separate accounting owns in full. The point here is narrower and more damning: if the oral precursors barely hold up, the IV infusion's evidence base is even more indefensible, because it skips straight to a needle with almost nothing behind it.
Now the other side of the ledger. The FDA has previously issued warnings about sterile-compounded NAD⁺ products due to severe endotoxin contamination risks that can harm patients.
Read those two facts together and you get the asymmetry the industry refuses to say out loud: near-zero proven upside, a documented safety signal on the downside. The entire transaction was risk in exchange for a promise with no clinical foundation.
Near-zero proven upside, a documented safety signal on the downside. The entire transaction was risk in exchange for a promise with no clinical foundation.
We do not yet know what killed Baron — contamination, dose, preparation error, or something intrinsic. The medical examiner will decide. But the structure that put her in that chair is already fully visible.
Cabrera's own record is a preview. Before Baron, he had been arrested at Newark Liberty twice in a matter of days — once with a metal baton, once when authorities found nearly 200 vials of prescription medications, more than 30 tablets, and 10 syringes containing lidocaine, per Israeli outlet Ynet. His website called him "Dr. Rojas," an M.D., surgeon and naturopath, and claimed more than 6,000 surgeries.
The gap between that self-presentation and an esthetician license is not an anomaly. It is the business model.
And it is not confined to one Bronx storefront. The same demand-versus-oversight gap that produced Cabrera is producing fake doctors at industrial scale online.
The New York Times reportedly found hundreds of AI-generated doctors, healers and wellness influencers on social media, touting supplement "medical miracles" in hyperrealistic ads that appear to target older women. The fabricated physician and the unlicensed one are the same product — authority costumed for a camera or a courtroom — sold to people who have no way to verify the person behind the claim.
The peptide market completes the picture. A hidden-camera investigation in Canada showed how trivially easy it is to buy unauthorized BPC-157, and one observer reported watching disposal boxes fill up at commercial gyms across southern Ontario, saying he was leaning toward peptides after discussions with staff and members.
Unlicensed clinics, AI-fabricated clinicians, gray-market peptides purchased over the internet — this is one ecosystem, not three anecdotes. Each channel exists because consumer demand for longevity has outrun the science and the regulators at the same time.
Longevity researcher Matt Kaeberlein has made a related point: "The danger increases dramatically when these interventions are provided by unlicensed practitioners, through offshore clinics, or obtained through unregulated channels, whether that's IV infusions, stem cells, or research-grade peptides purchased over the internet."
He also noted this is not the first fatality-adjacent episode. At RAADfest last year, injections purporting to contain peptides, offered where some practitioners reportedly were not properly licensed, reportedly nearly killed two people, according to longevity outlet Lifespan.io.
So what does enforcement actually look like when a state tries? New York gives us the numbers, and they are sobering in both directions.
Secretary of State Walter Mosley's office has completed over 337 med spa inspections. Of those, 24 were shut down by emergency order and 16 lost their license. Inspectors found expired drugs, counterfeit products, and even fentanyl.
That is real work. It is also reactive, and it lands after storefronts are already open and needles are already in arms.
The consumer-protection frame that cuts through the noise comes from Dr. Tommaso Addona, a board-certified plastic surgeon, who described three licenses a patient should always verify: the person, the building, and the bottle.
The person administering the injection needs a license. The facility hosting them needs a license. And the product needs to come from a manufacturer authorized and approved to make it.
Run Baron's death through that filter and all three fail at once. In New York, his only valid license was an esthetician license (he also claimed a Dominican Republic medical license and a Puerto Rico PA license). The clinic was operating outside the medical framework New York requires. And the bottle — compounded NAD⁺ — sits under an existing FDA warning for endotoxin contamination.
"Terrified for patients is how I felt," Addona said when he learned what happened in the Bronx.
Dr. Andrea Maier, one of the field's academic pioneers, frames the fix without flinching: "Healthy Longevity Medicine is a medical discipline and, like every other medical discipline, it must be grounded in evidence, clinical governance, and patient safety." The failure, she argues, is that the field created enormous public appetite without teaching the public what is proven, what is experimental, and what is unvalidated.
IV NAD⁺ for longevity sits squarely in that last category — unvalidated, and now attached to a body.
Until "longevity medicine" enforces the three-license standard as a floor, and until states can inspect at the speed demand actually moves, cases like Baron's will keep arriving. Not as accidents.
As output. The system is doing exactly what its incentives tell it to do.
That is the uncomfortable part. A 27-year-old walked in for something sold as anti-aging, received an intervention with a near-empty evidence base and a real contamination signal, from a man whose only relevant credential was in skincare — and died within the hour.
The body count, under the current rules, is a feature. Not a bug.